News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.
Trial
Simmons Cancer Institute

BC-IMT-04: Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)

Active recruiting

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.

News

Announcing “Illuminate the Night” to support Alzheimer’s care and research

The Dale and Deborah Smith Center for Alzheimer’s Research and Treatment is proud to announce the inaugural Illuminate the Night , an evening dedicated to raising funds for Alzheimer’s care, research, and outreach programs. Scheduled for June 14, 2025 at Crowne Plaza in Springfield, IL, this unforgettable event will feature entertainment, a live auction and a chance for the community to make a meaningful impact. Illuminate the Night brings together donors, caregivers and community members with a shared mission: to brighten the path for individuals living with dementia and their loved ones. The
News

Celebrating Healthcare Continuing Education Professionals Day

Healthcare Continuing Education Professionals Day™ (January 24) is a special occasion dedicated to honoring the individuals who keep health care providers informed and equipped to deliver exceptional patient care. At SIU School of Medicine, we are proud to celebrate our continuing medical education (CME) professionals, whose work fosters lifelong learning, strengthens interprofessional collaboration and drives improvements in health care outcomes. Their efforts not only help providers stay current with medical advancements but also directly contribute to safer, more effective patient care. The
Subscribe to Research